Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- New Medical Fee Payment System Proposed
April 7, 2003
- AnGes MG Embarks on Joint Research with Osaka Univ., Shimadzu
April 7, 2003
- OTC NEWS IN BUEF
April 7, 2003
- Basic Policy for Medical Insurance, Medical Fee Payment System Reform Approved by LDP
April 7, 2003
- Sosei, Abgenix to Codevelop Antibodies against CRTh2
April 7, 2003
- Mitsubishi Kagaku Medical, Iatron, Dia-Iatron to Be Integrated in July
April 7, 2003
- NHI Listing for 4 Active Ingredients Including Sevelamer HCl
April 7, 2003
- Kyowa Hakko Starts Large Clinical Study on Coniel in Japan
April 7, 2003
- DIAGNOSTIC NEWS IN BRIEF
April 7, 2003
- Cabinet Draft Decision Calls For Measures to Expand Patient Choice: Deregulation Plan
April 7, 2003
- Data on Similar Drugs Required for Risk Benefit Analysis: RAD-AR Council Japan
April 7, 2003
- Nihon Schering Publishes Its 50-year History
April 7, 2003
- Korosho Issues Checklist to Promote GE Drug Use in Nat'l Hospital
April 7, 2003
- Atypical Antipsychotic Agents Useful in Maintenance Therapy
April 7, 2003
- Trend Toward For-profit Participation in Healthcare "Will Not Stop": Mr Konoike
March 31, 2003
- NEW PRODUCTS
March 31, 2003
- Korosho Orders Kyorin to Issue Dear-Dr Letter on Gatifloxacin
March 31, 2003
- Vision for Medical Devices Industry Announced
March 31, 2003
- REGULATORY NEWS IN BRIEF
March 31, 2003
- Notification on Safety Measures for Infusion Pumps Issued
March 31, 2003
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…